|
|
||||||||
Clinical Investigations |
1 PET Department, Clinical Center, National Institutes of Health, Bethesda, Maryland
2 Postgraduate Specialty School in Nuclear Medicine, University of Pisa Medical School, Pisa, Italy
3 Clinical Epilepsy Section, National Institute of Neurological Diseases and Strokes, National Institutes of Health, Bethesda, Maryland
Preclinical studies suggest that serotonin 1A receptors (5-HT1A) play a role in temporal lobe epilepsy (TLE). Previous PET studies reported decreased 5-HT1A binding ipsilateral to epileptic foci but did not correct for the partial-volume effect (PVE) due to structural atrophy. Methods: We used PET with 18F-trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl-N-(2-pyridyl)cyclohexanecarboxamide (18F-FCWAY), a 5-HT1A receptor antagonist, to study 22 patients with TLE and 10 control subjects. In patients, 18F-FDG scans also were performed. An automated MR-based partial-volume correction (PVC) algorithm was applied. Psychiatric symptoms were assessed with the Beck Depression Inventory Scale. Results: Before PVC, significant (uncorrected P < 0.05) reductions of 18F-FCWAY binding potential (BP) were detected in both mesial and lateral temporal structures, mainly ipsilateral to the seizure focus, in the insula, and in the raphe. Group differences were maximal in ipsilateral mesial temporal regions (corrected P < 0.05). After PVC, differences in mesial, but not lateral, temporal structures and in the insula remained highly significant (corrected P < 0.05). Significant (uncorrected P < 0.05) BP reductions were also detected in TLE patients with normal MR images (n = 6), in mesial temporal structures. After PVC, asymmetries in BP remained significantly greater than for glucose metabolism in hippocampus and parahippocampus. There was a significant inverse relation between the Beck Depression score and the ipsilateral hippocampal BP, both before and after PVC. Conclusion: Our study shows that in TLE patients, reductions of 5-HT1A receptor binding in mesial temporal structures and insula are still significant after PVC. In contrast, partial-volume effects may be an important contributor to 5-HT1A receptor-binding reductions in lateral temporal lobe. Reduction of 5-HT1A receptors in the ipsilateral hippocampus may contribute to depressive symptoms in TLE patients.
Key Words: 5-HT1A receptors temporal lobe epilepsy partial-volume correction PET depression
This article has been cited by other articles:
![]() |
A. Lothe, A. Didelot, A. Hammers, N. Costes, M. Saoud, F. Gilliam, and P. Ryvlin Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study Brain, September 2, 2008; (2008) awn194v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kato, E. Shimosegawa, N. Oku, K. Kitagawa, H. Kishima, Y. Saitoh, A. Kato, T. Yoshimine, and J. Hatazawa MRI-Based Correction for Partial-Volume Effect Improves Detectability of Intractable Epileptogenic Foci on 123I-Iomazenil Brain SPECT Images J. Nucl. Med., March 1, 2008; 49(3): 383 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakayama, Y. Ouchi, E. Yoshikawa, G. Sugihara, T. Torizuka, and K. Tanaka Striatal D2 Receptor Availability After Shunting in Idiopathic Normal Pressure Hydrocephalus J. Nucl. Med., December 1, 2007; 48(12): 1981 - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Lanctot, D. F. Hussey, N. Herrmann, S. E. Black, P. M. Rusjan, A. A. Wilson, S. Houle, N. Kozloff, N. P. L.G. Verhoeff, and S. Kapur A Positron Emission Tomography Study of 5-Hydroxytryptamine-1A Receptors in Alzheimer Disease Am J Geriatr Psychiatry, October 1, 2007; 15(10): 888 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Ryu, J.-S. Liow, S. Zoghbi, M. Fujita, J. Collins, D. Tipre, J. Sangare, J. Hong, V. W. Pike, and R. B. Innis Disulfiram Inhibits Defluorination of 18F-FCWAY, Reduces Bone Radioactivity, and Enhances Visualization of Radioligand Binding to Serotonin 5-HT1A Receptors in Human Brain J. Nucl. Med., July 1, 2007; 48(7): 1154 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Gaillard, S. Weinstein, J. Conry, P. L. Pearl, S. Fazilat, S. Fazilat, L. G. Vezina, P. Reeves-Tyer, and W. H. Theodore Prognosis of children with partial epilepsy: MRI and serial 18FDG-PET Neurology, February 27, 2007; 68(9): 655 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Gilliam, B. M. Maton, R. C. Martin, S. M. Sawrie, R. E. Faught, J. W. Hugg, M. Viikinsalo, and R. I. Kuzniecky Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy Neurology, January 30, 2007; 68(5): 364 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Hurley, R. Fisher, and K. H. Taber Sudden Onset Panic: Epileptic Aura or Panic Disorder? J Neuropsychiatry Clin Neurosci, November 1, 2006; 18(4): 436 - 443. [Full Text] [PDF] |
||||
![]() |
N. Saigal, R. Pichika, B. Easwaramoorthy, D. Collins, B. T. Christian, B. Shi, T. K. Narayanan, S. G. Potkin, and J. Mukherjee Synthesis and Biologic Evaluation of a Novel Serotonin 5-HT1A Receptor Radioligand, 18F-Labeled Mefway, in Rodents and Imaging by PET in a Nonhuman Primate J. Nucl. Med., October 1, 2006; 47(10): 1697 - 1706. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |